Last edition
News about "Viralgen"
Viralgen Partners with Elaaj Bio to Advance Gene Therapy for CDKL5 Deficiency Disorder
Viralgen partners with Elaaj Bio to advance an AAV-based gene therapy program for CDKL5 Deficiency Disorder, leveraging specialised manufacturing expertise.
Viralgen | 06/05/2026 | By News Bureau
AskBio's Viralgen to Supply Commercial Drug for Parkinson's Phase 2 Trial
AskBio’s Viralgen will supply commercial-scale drug product for the REGENERATE-PD Phase II trial of ametefgene parvec (AB-1005), leveraging next-generation manufacturing to deliver high-purity gene therapy for Parkinson’s disease.
Viralgen | 22/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy